Knockdown of Rab7B, but not of Rab7A, which antagonistically regulates oligodendroglial cell morphological differentiation, recovers tunicamycin-induced defective differentiation in FBD-102b cells

doi:10.21203/rs.3.rs-2493702/v1

Download PDF

Research Article

Knockdown of Rab7B, but not of Rab7A, which antagonistically regulates oligodendroglial cell morphological differentiation, recovers tunicamycin-induced defective differentiation in FBD-102b cells

https://doi.org/10.21203/rs.3.rs-2493702/v1

This work is licensed under a CC BY 4.0 License

Version 1

posted

You are reading this latest preprint version

In the central nervous system (CNS), insulative myelin sheaths are generated from the differentiated plasma membranes of oligodendrocytes (oligodendroglial cells) and surround neuronal axons to achieve saltatory conduction. Despite the functional involvement of myelin sheaths in the CNS, the molecular mechanism by which oligodendroglial cells themselves undergo differentiation of plasma membranes remains unclear. It also remains to be explored whether their signaling mechanisms can be applied to treating diseases of the oligodendroglial cells. Here we describe that Rab7B of Rab7 subfamily small GTPases negatively regulates oligodendroglial cell morphological differentiation using FBD-102b cells, which are model cells undergoing differentiation of oligodendroglial precursors. Knockdown of Rab7B or Rab7A by the respective specific siRNAs in cells positively or negatively regulated morphological differentiation, respectively. Consistently, these changes were supported by changes on differentiation- and myelination-related structural protein and protein kinase markers. We also found that knockdown of Rab7B has the ability to recover inhibition of morphological differentiation following tunicamycin-induced endoplasmic reticulum (ER) stress, which mimics one of the major molecular pathological causes of hereditary hypomyelinating disorders in oligodendroglial cells, such as Pelizaeus-Merzbacher disease (PMD). These results suggest that the respective molecules among very close Rab7 homologues exhibit differential roles in morphological differentiation and that knocking down Rab7B can recover defective differentiating phenotypes under ER stress, thereby adding Rab7B to the list of molecular therapeutic cues taking advantage of signaling mechanisms for oligodendroglial diseases like PMD.

oligodendrocyte

differentiation

myelination marker

Rab7A

Rab7B

ER stress

Rab family proteins belong to a small GTPase molecular branch [1–3]. Rab proteins are the master regulator molecules that control basic cellular functions to mediate intracellular vesicle trafficking to fuse with their cognate target membrane or vesicle [1–3]. Different or similar Rab proteins are localized on the respective organelles such as the endoplasmic reticulum (ER), Golgi body, and intermediate components between organelles including ones between the ER and the Golgi body as well as the early, recycling, and late endosomes. Thus, to distinguish these intracellular vesicles or components, it is believed that there are over 40 species of Rab proteins [1–4]. And, some Rab proteins are redundant in organelles or transporting systems whereas others are unique and may be essential for them [1–4].

Among Rab proteins, Rab7A and Rab42 (also called Rab7B) subfamily molecules are unique, since only Rab7 subfamily of the Rab proteins specifically participates in membrane trafficking around lysosomes and late endosomes [1–4]. Rab7A is well studied compared to Rab7B [1–4]. It is known that Rab7A and to a lesser extent Rab7B play roles not only in lysosomal biosynthesis, positioning, and function but also in the transport and degradation of cell surface receptors and adhesion molecules [4–9]. It is likely that Rab7A and Rab7B actually display differential localization; Rab7A exhibits probable specific localization in late endosomes and lysosomes whereas Rab7B is localized in the trans-Golgi networks, late endosomes, and lysosomes [4–10].

During development, myelin sheaths are formed from differentiated plasma membranes of oligodendrocytes (also called oligodendroglial cells) in the central nervous system and Schwann cells in the peripheral nervous system. The membranes wrap around neuronal axons where they become multiple layers of myelin. The myelin sheaths often grow to become much larger than the collective surface areas of the plasma membranes prior to myelination. Mature myelin not only aids in conduction propagation but also protects axons from some stresses [11–14]. It also contributes to supplying some nutrients to neuronal axons [11–16].

The question of whether Rab proteins that hold basic and key cell biological roles are actually involved in the regulation of morphological differentiation in oligodendroglial cells remains unanswered. It also remains unclear whether the unique Rab7 protein contributes to differentiation. If so, how Rab7A and Rab7B regulate differentiation needs to be determined. Herein we describe that Rab7A and Rab7B differentially regulate morphological differentiation in FBD-102b cells, which are models of differentiation of oligodendroglial precursor cells [17–20]. It is of note that knockdown of Rab7B greatly promoted differentiation. This finding reminded us of the possibility that knockdown of Rab7B recovers disease-associated undifferentiated states. As expected, Rab7B knockdown recovered undifferentiated morphologies induced by treatment with tunicamycin, which mimics endoplasmic reticulum (ER) stress [21, 22]. It is thought that ER stress is one of the major pathological causes observed in Pelizaeus-Merzbacher disease (PMD, also called hypomyelinating leukodystrophy 1 [HLD1]) and some other neuropathies [12, 23, 24]. Oligodendroglial cells in PMD often display insufficient differentiated phenotypes [25, 26]. Differential effects of Rab7 subfamily members on oligodendroglial cell morphological differentiation may provide some hints for the potential target to treat oligodendroglial cell diseases such as PMD.

2.1. Antibodies and chemicals

Antibodies and chemicals are listed in Table 1.

2.2. siRNA and primer nucleotide sequences and PCR techniques

Nucleotide sequences for siRNAs and primers are described in Table 1. For reverse transcription-polymerase chain reaction (RT-PCR), cDNAs were prepared from Isogen (Nippon Gene, Tokyo, Japan)-extracted total RNA with the PrimeScript RT Master Mix kit (Takara Bio, Kyoto, Japan) in accordance with the manufacturer’s instructions. PCR amplification (see Table 1 for DNA primers) from RT products was performed using Gflex DNA polymerase (Takara Bio) with 30 to 36 cycles, each consisting of a denaturation reaction at 98°C (0.2 min), an annealing reaction at 56 to 65°C (0.25 min) depending on the annealing temperature, and an extension reaction at 68°C (0.5 min). The resultant PCR products were loaded onto 1–2% agarose gels (Nacalai Tesque, Kyoto, Japan).

2.3. Cell culture, differentiation, and transfection

FBD-102b cells (provided by Dr. Tomo-Oka, Tokyo University of Science), which belong to an oligodendroglial precursor cell line [17–20], were cultured on normal cell culture dishes (Nunc brand, Thermo Fisher Scientific, Waltham, MA, USA) in Dulbecco’s modified Eagle’s medium (DMEM)/F-12 mixed medium (Nacalai Tesque) containing 10% heat-inactivated fetal bovine serum (FBS; Gibco brand, Thermo Fisher Scientific) and penicillin and streptomycin mixed solution (Nacalai Tesque) in 5% CO₂ at 37°C. Cells were transfected with the respective synthesized 21-mer siRNAs with dTdT using the ScreenFect siRNA transfection kit (Fujifilm, Tokyo, Japan) in accordance with the manufacturer’s instructions. The medium was replaced 4 hours after transfection and cells were further cultured for experiments. Less than 5% of attached cells contained incorporated trypan blue (Nacalai Tesque) at 48 hours after transfection [17–20].

To induce differentiation, cells were cultured on polylysine (Nacalai Tesque)-coated cell culture dishes (Greiner Bio-One, Oberösterreich, Austria) in culture medium without FBS until 5 days in 5% CO₂ at 37°C [17–20]. Cells with no primary process were classified as category 1; cells with primary processes were classified as category 2; and cells with secondary processes branched from primary processes or with myelin membrane-like widespread processes were classified as category 3 [17–20]. Category 2 corresponded to these intermediate phenotypes. Cell morphologies (10 fields) were randomly captured using microscopic systems equipped with i-NTER LENS (Micronet, Inc., Saitama, Japan).

2.4. Cell lysis and immunoblotting

Cells were lysed in lysis buffer (50 mM HEPES-NaOH, pH 7.5, 150 mM NaCl, 20 mM MgCl₂, 1 mM dithiothreitol, 1 mM phenylmethane sulfonylfluoride, 1 µg/ml of leupeptin, 1 mM EDTA, 1 mM Na₃VO₄, 10 mM NaF, and 0.5% NP-40) and collected by centrifugation as cell lysates [27, 28]. Their supernatants were denatured with a sample buffer (Nacalai Tesque). The samples were separated on pre-made sodium dodecylsulfate–polyacrylamide gels (Nacalai Tesque) [27, 28]. The electrophoretically separated proteins were transferred to PVDF membranes (Fujifilm) sandwiched between filter papers (Fujifilm), blocked with Blocking One (Nacalai Tesque), and immunoblotted using primary antibodies, followed by peroxidase-conjugated secondary antibodies. A CanoScan LiDE400 image scanner (Canon, Tokyo, Japan) captured the peroxidase-reactive bands on X-ray films (Fujifilm). They were digitally scanned using UN-SCAN-IT software (Silk Scientific, Orem, UT, USA). Quantified immunoreactive bands (3 blots) were compared with the control’s immunoreactive bands, which were set to 100%, using Image J software (NIH, Bethesda, MD, USA).

2.5. Statistical analyses

Values are means ± standard deviation (SD) from separate experiments. Intergroup comparisons were made using the unpaired Student’s t-test using Excel (Microsoft, Redmond, WA, USA). A one-way analysis of variance (ANOVA) was followed by a Tukey’s multiple comparison test using Graph Pad Prism (GraphPad Software, San Diego, CA, USA). Differences were considered statistically significant when p < 0.05.

2. 6. Ethics Statements

Gene recombination techniques in vitro and in vivo were performed in accordance with a protocol approved by the Tokyo University of Pharmacy and Life Sciences Gene and Animal Care Committee (Approval Nos. LS28-20 and LSR3-011).

3.1. Rab7A positively affects morphological differentiation

In order to investigate whether Rab7A is involved in the regulation of oligodendroglial cell morphological differentiation, we transfected siRNA (Figure S1) specific for Rab7A into FBD-102b cells. Knockdown of Rab7A but not control luciferase resulted in inhibiting morphological differentiation (Fig. 1, A and B). These changes were accomplished with decreased expression levels of differentiation and myelination marker proteins MBP and PLP1 (Fig. 2, A and B). In contrast, the levels of control actin proteins were comparable in Rab7A and control knocked-down cells, suggesting that Rab7A is involved in promoting morphological differentiation.

3.1. Rab7B negatively affects morphological differentiation

Next, we transfected siRNA (Figure S1) specific for Rab7B into cells. Knockdown of Rab7B but not control luciferase resulted in promoting oligodendroglial cell morphological differentiation (Fig. 3, A and B). The knockdown also increased the expression levels of differentiation and myelination marker proteins but it did not affect the levels of control proteins (Fig. 4, A and B), indicating that Rab7B plays an inhibitory role in morphological differentiation.

3.3. Knockdown of Rab7B recovers tunicamycin-induced defective morphological differentiation

The results pertaining to the effects of Rab7B on morphological differentiation suggested the possibility that knockdown of Rab7B could help recover the inhibitory morphological differentiation in disease states [25, 26]. We induced ER stress using tunicamycin [21, 22] and mimicked cellular disease states, as often observed in oligodendroglial cell diseases [23, 24] and many other neurological diseases [11, 12]. In fact, tunicamycin inhibited morphological differentiation in a dose-dependent manner in FBD-102b cells (Figure S2). In addition, tunicamycin upregulated ER stress signals, which have included increased phosphorylation levels of JNK and eIF2A. Phosphorylating JNK and eIF2A primarily act downstream of ER stress signaling [29, 30]. In contrast, it did not affect the expression levels of JNK and eIF2A themselves.

As expected, under these experimental conditions, knockdown of Rab7B recovered tunicamycin-induced inhibition of morphological differentiation (Fig. 5, A and B) with increased expression levels of marker proteins (Fig. 6, A and B), identifying Rab7B as an effective target for recovering ER stress–induced inhibition of morphological differentiation.

In contrast, knockdown of Rab7A failed to recover the tunicamycin-induced inhibitory effects of morphological differentiation (Figure S3) as well as those of the expression levels of marker proteins (Figure S4).

3.4. Knockdown of Rab7B recovers tunicamycin-induced ER stress signaling

Finally, we asked whether Rab7B knockdown could recover ER stress signals. Knockdown of Rab7B in cells resulted in decreasing phosphorylation levels of JNK and eIF2A whereas the expression levels of JNK and eIF2A were comparable regardless of knockdown states (Fig. 7, A-D). Taken together with the above results, Rab7B knockdown can be effective against tunicamycin-induced ER stress.

Rab7A and Rab7B display ubiquitous expressions in a variety of cells and tissues and are directly involved in the regulation of the transporting system between late endosomes and lysosomes [31–34]. It is thus thought that functional deficiency of Rab7 subfamily molecules is directly linked to deficiency of the intracellular transporting system between late endosomes and lysosomes to control protein states, such as their quality [31–34]. It is natural for the deficiency to also be related to malfunction of autophagy in cell homeostasis [31–34]. In addition to these organelle functional deficiencies, for example, there is often decreased lysosomal signaling related to the mechanistic target of rapamycin (mTOR) as a master regulator of basic cellular signaling pathways [35, 36]. It is therefore likely that Rab7A and Rab7B are important to many aspects of basic cellular functions.

In fact, some amino acid mutations of Rab7A result in progressive neuropathy in the peripheral nervous system. This is evident in autosomal-dominant Charcot-Marie-Tooth type 2B (CMT2B) disease, in which the common features are distal sensory loss, foot calluses, and poorly healing ulcers [37–40]. Of interest, all mutations of Rab7A appear likely to generate constitutively activated Rab7A [40, 41]. To achieve cell physiological function, including transporting between late endosomes and lysosomes, Rab proteins generally require cycles between the active GTP-bound form and the inactive GDP-bound form [1–3]. The switching cycle is essential for transporting the related vesicles [1–3]. It is thus presumed that the presence of GTP-locked Rab7A in cells blocks vesicle recycling; however, it remains unclear why GTP-locked Rab7A is specifically associated with triggering peripheral neuropathy. Additionally, it remains unknown whether mutations of Rab7B cause CMT2B and the other peripheral neuropathies. In this study, we describe for the first time that knockdown of Rab7A but not Rab7B in oligodendroglial cell line FBD-102b leads to inhibition of its morphological differentiation, indicating that Rab7A is required for differentiation. We previously reported that GTP-locked Rab7A inhibits neuronal cell morphological differentiation in N1E-115 cells, which are used as a neuronal differentiation model in the central nervous system [18, 42]. It is likely that in the central nervous system cells, Rab7A plays key roles in morphological differentiation in both neuronal and glial cells. Further studies will allow us to determine whether Rab7A is actually responsible for central nervous system diseases.

In addition to the transporting system between late endosomes and lysosomes, Rab7B is believed to participate in regulating the transporting system in trans-Golgi networks [5–9]. Rab7B specifically regulates retrograde vesicle trafficking between late endosomes and trans-Golgi networks [5–9]. In the present study, we provide evidence that knockdown of Rab7B but not Rab7A in cells promotes oligodendroglial morphological differentiation, revealing that Rab7B is a negative regulator for differentiation. The reason for this may be that retrograde transporting between late endosomes and trans-Golgi networks can provide an unnecessary transporting pathway to oligodendroglial cells, although the precise cellular roles of this retrograde transporting system remain to be answered so far. Since mature differentiated myelin sheaths often grow to become more than 100-fold larger than the collective surface areas of the premyelinating plasma membranes, it is conceivable that intracellular systems transporting myelin membrane components are significantly activated and that anterograde transporting systems take precedence over retrograde ones. Alternatively, Rab7B has some specific roles in oligodendroglial cells. It is known that Rab7A binds to effectors such as RLIP (Rab-interacting lysosomal protein) and more than 100 binding partners (see the BioGRID website: https://thebiogrid.org/), possibly to elicit its function, although the interaction of Rab7B with its proteins has not been thoroughly investigated. In oligodendroglial cells, some effector proteins may specifically bind to Rab7A and others may bind only to Rab7B. To the best of our knowledge, the molecular mechanism in which Rab7B and Rab7A antagonistically regulates morphogenesis during differentiation has been unanticipated to date.

Although many of the oligodendroglial cell degenerative diseases (also called oligodendropathies) are serious, their therapeutic target molecules have been unknown. One of the oligodendropathies is PMD [25, 26]. PMD is associated with various gene mutations, including amplification of the plp1 gene encoding major myelin plasma membrane protein, resulting in PLP1 accumulating in the ER. It is thought that the misfolded PLP1 proteins trigger ER stress, causing cell pathological phenotypes of oligodendropathies [21, 23, 25, 26]. One of the phenotypes results in the increase of undifferentiated and/or hypomyelinating oligodendroglial cells. It is thus thought that decreased ER stress recovers cell pathological phenotypes [22, 25, 26]. In fact, some chemicals to decrease ER stress reverse pathological phenotypes by ER stress inducers such as tunicamycin [22]. We have established a hypothesis that knockdown of Rab7B may promote defective differentiation by tunicamycin-induced ER stress. Knockdown of Rab7B indeed recovers tunicamycin-induced defective differentiation. In addition, its knockdown decreases ER stress signaling.

The last question in this study, whether Rab7B regulates ER stress, remains unanswered. On the other hand, Mateus et al. reported the close relationship between Rab7A and ER stress in human epithelial and epithelial-like cells [43]. Knockdown of Rab7A by the cognate iRNA or expression of dominantly inhibitory mutant constructs expands sheet-like ER structures to spread cell peripheries. Inhibition of Rab7A induces ER stress to cause enlargement of ER structures whereas re-expression of Rab7A in the experimental conditions decreases ER stress and rescues enlarging phenotypes of the ER. Rab7A appears likely to maintain cell homeostasis by controlling the ER. Loi et al. provided key evidence that endo-lysosomes positive to antigens of both Rab7, possibly Rab7A, and lysosomal-associated membrane protein 1 (LAMP1) engulf the excess ER [44]. Although the ER engulfed by endo-lysosomes is not specified, they could engulf the ER with excess stress to maintain cell homeostasis. During these processes, Rab7A might critically mediate cell homeostasis centered to the ER.

Herein we demonstrate that Rab7A and Rab7B positively and negatively regulates oligodendroglial cell morphological differentiation, respectively, as established by changes in differentiation marker proteins. Knockdown of Rab7B rescues defective morphological differentiation by tunicamycin-induced ER stress, as established by changes in phosphorylation levels of ER stress–regulated kinase (Figure S5). It is also possible that Rab7B can mediate naturally occurring ER stress under cell homeostasis oligodendroglial cells. Additional studies would promote our understanding not only of the detailed molecular mechanism by which Rab7A and Rab7B regulate morphological differentiation, but also which target downstream molecule of Rab7A and Rab7B regulates differentiation and, in turn, myelination in the primary cell, coculture, and mouse levels. Further studies will allow us to clarify whether Rab7B is one of the therapeutic targets of PMD and the related oligodendroglial cell diseases. Studies in this line may lead to the development of target-specific medicines, taking advantage of the common molecular and cellular pathological signaling underlying diseases involving ER stress in the central nervous system

Acknowledgements

We thank Drs. Takako Morimoto and Yoichi Seki (Tokyo University of Pharmacy and Life Sciences) for the insightful comments they provided throughout this study.

Funding sources

This work was supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Grants-in-Aid for Medical Scientific Research from the Japanese Ministry of Health, Labor and Welfare (MHLW). This work was also supported by grants from Daiichi Sankyo Science Foundation (Daiichi Sankyo Company, Limited), Takeda Science Foundation (Takeda Pharmaceutical Company, Limited), and Mitsubishi Tanabe Pharma Foundation (Mitsubishi Tanabe Pharma).

Author contributions

Junji Yamauchi and Yuki Miyamoto designed this study, wrote this manuscript, and edited it. Nana Fukushima, Remina Shirai, Takanari Sato, Sayumi Nakamura, and Arisa Ochiai performed the experiments. Nana Fukushima and Remina Shirai performed the statistical analyses.

Competing interests

The authors have declared that no competing interests exist.

Pfeffer SR, Soldati T, Geissler H, Rancaño C, Dirac-Svejstrup B (1995) Selective membrane recruitment of Rab GTPases. Cold Spring Harb. Symp. Quant. Biol. 60:221–227
Ng EL, Tang BL (2008) Rab GTPases and their roles in brain neurons and glia. Brain Res Rev 58:236–246
Homma Y, Hiragi S, Fukuda M (2021) Rab family of small GTPases: An updated view on their regulation and functions. FEBS J 288:36–55
Snider M D. A role for Rab7 GTPase in growth factor-regulated cell nutrition and apoptosis.Mol. Cell 200312:796–797
Progida C, Cogli L, Piro F, De Luca A, Bakke O, Bucci C (2010) Rab7b controls trafficking from endosomes to the TGN. J Cell Sci 123:1480–1491
Borg M, Bakke O, Progida C (2014) A novel interaction between Rab7b and actomyosin reveals a dual role in intracellular transport and cell migration. J Cell Sci 127:4927–4939
Distefano MB, Kjos I, Bakke O, Progida C (2015) Rab7b at the intersection of intracellular trafficking and cell migration. Commun Integr Biol 8:e1023492
Marubashi S, Fukuda M, Rab (2020) 7B/42 Is functionally involved in protein degradation on melanosomes in keratinocytes. Cell Struct Funct 45:45–55
Vestre K, Persiconi I, Borg Distefano M, Mensali N, Guadagno NA, Bretou M, Wälchli S, Arnold-Schrauf C, Bakke O, Dalod M, Lennon-Dumenil AM, Progida C (2021) Rab7b regulates dendritic cell migration by linking lysosomes to the actomyosin cytoskeleton. J Cell Sci 134:jcs259221
Tian X, Teng J, Chen J New insights regarding SNARE proteins in autophagosome-lysosome fusion.Autophagy 202117:2680–2688
Simons M, Nave KA, Oligodendrocytes (2015) Myelination and axonal support. Cold Spring Harb Perspect Biol 8:a020479
Barateiro A, Brites D, Fernandes A (2016) Oligodendrocyte development and myelination in neurodevelopment: Molecular mechanisms in health and disease. Curr Pharm Des 22:656–679
Elbaz B, Popko B (2019) Molecular control of oligodendrocyte development. Trends Neurosci 42:263–277
Adams KL, Dahl KD, Gallo V, Macklin WB (2021) Intrinsic and extrinsic regulators of oligodendrocyte progenitor proliferation and differentiation. Semin Cell Dev Biol 116:16–24
Bercury KK, Dai J, Sachs HH, Ahrendsen JT, Wood TL, Macklin WB (2014) Conditional ablation of raptor or rictor has differential impact on oligodendrocyte differentiation and CNS myelination. J Neurosci 34:4466–4480
Figlia G, Gerber D, Suter U (2018) Myelination and mTOR. Glia 66:693–707
Miyamoto Y, Yamauchi J, Chan JR, Okada A, Tomooka Y, Hisanaga S, Tanoue A (2007) Cdk5 regulates differentiation of oligodendrocyte precursor cells through the direct phosphorylation of paxillin. J Cell Sci 120:4355–4366
Urai Y, Yamawaki M, Watanabe N, Seki Y, Morimoto T, Tago K, Homma K, Sakagami H, Miyamoto Y, Yamauchi J (2018) Pull down assay for GTP-bound form of Sar1a reveals its activation during morphological differentiation. Biochem Biophys Res Commun 503:2047–2205
Nishino S, Fujiki Y, Sato T, Kato Y, Shirai R, Oizumi H, Yamamoto M, Ohbuchi K, Miyamoto Y, Mizoguchi K, Yamauchi J (2022) Hesperetin, a citrus flavonoid, ameliorates inflammatory cytokine-mediated inhibition of oligodendroglial cell morphological differentiation. Neurol Int 14:471–487
Kato Y, Tago K, Fukatsu S, Okabe M, Shirai R, Oizumi H, Ohbuchi K, Yamamoto M, Mizoguchi K, Miyamoto Y (2022) Yamauchi, J. CRISPR/CasRx-mediated RNA knockdown reveals that ACE2 is involved in the regulation of oligodendroglial cell morphological differentiation. Non-Coding RNA 8:42
Morimura T, Numata Y, Nakamura S, Hirano E, Gotoh L, Goto YI, Urushitani M, Inoue K (2014) Attenuation of endoplasmic reticulum stress in Pelizaeus-Merzbacher disease by an anti-malaria drug, chloroquine. Exp Biol Med 239:489–501
Wilding AS, Patte-Mensah C, Taleb O, Brun S, Kemmel V, Mensah-Nyagan AG (2018) Protective effect of 4-phenylbutyrate against proteolipid protein mutation-induced endoplasmic reticulum stress and oligodendroglial cell death. Neurochem Int 118:185–194
Dhaunchak AS, Colman DR, Nave KA (2011) Misalignment of PLP/DM20 transmembrane domains determines protein misfolding in Pelizaeus-Merzbacher disease. J Neurosci 31:14961–14971
Wrabetz L, D'Antonio M, Pennuto M, Dati G, Tinelli E, Fratta P, Previtali S, Imperiale D, Zielasek J, Toyka K, Avila RL, Kirschner DA, Messing A, Feltri ML, Quattrini A (2006) Different intracellular pathomechanisms produce diverse Myelin Protein Zero neuropathies in transgenic mice. J Neurosci 26:2358–2368
Torii T, Miyamoto Y, Yamauchi J, Tanoue A (2014) Pelizaeus-Merzbacher disease: cellular pathogenesis and pharmacologic therapy. Pediatr Int 56:659–666
Wolf NI, Ffrench-Constant C, van der Knaap MS (2021) Hypomyelinating leukodystrophies - unravelling myelin biology. Nat Rev Neurol 17:88–103
Miyamoto Y, Torii T, Tago K, Tanoue A, Takashima S, Yamauchi J (2018) BIG1/Arfgef1 and Arf1 regulate the initiation of myelination by Schwann cells in mice. Sci Adv 4:eaar4471
Miyamoto Y, Torii T, Homma K, Oizumi H, Ohbuchi K, Mizoguchi K, Takashima S, Yamauchi J (2022) The adaptor SH2B1 and the phosphatase PTP4A1 regulate the phosphorylation of cytohesin-2 in myelinating Schwann cells in mice. Sci Signal 15:eabi5276
Urano F, Wang X, Bertolotti A, Zhang Y, Chung P, Harding HP, Ron D (2000) Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287:664–666
Hotamisligil GS, Davis RJ (2016) Cell signaling and stress responses. Cold Spring Harb Perspect Biol 8:a006072
Wang T, Ming Z, Xiaochun W, Hong W (2011) Rab7: Role of its protein interaction cascades in endo-lysosomal traffic. Cell Signal 23:516–521
Balderhaar HJ, Ungermann C (2013) CORVET and HOPS tethering complexes - coordinators of endosome and lysosome fusion. J Cell Sci 126:1307–1316
Kuchitsu Y, Fukuda M (2018) Revisiting Rab7 functions in mammalian autophagy: Rab7 knockout studies. Cells 7:215
Stroupe C (2018) This is the end: regulation of Rab7 nucleotide binding in endolysosomal trafficking and autophagy. Front Cell Dev Biol 6:129
Condon KJ, Sabatini DM (2019) Nutrient regulation of mTORC1 at a glance. J Cell Sci 132:jcs2225
Bar-Peled L, Sabatini DM (2014) Regulation of mTORC1 by amino acids. Trends Cell Biol 24:400–406
Shy ME (2004) Charcot-Marie-Tooth disease: An update. Curr Opin Neurol 17:579–585
Auer-Grumbach M (2004) Hereditary sensory neuropathies. Drugs Today 40:385–394
Verhoeven K, Timmerman V, Mauko B, Pieber TR, De Jonghe P, Auer-Grumbach M (2006) Recent advances in hereditary sensory and autonomic neuropathies. Curr Opin Neurol 19:474–480
Cogli L, Piro F, Bucci C (2009) Rab7 and the CMT2B disease. Biochem Soc Trans 37:1027–1031
Yamauchi J, Torii T, Kusakawa S, Sanbe A, Nakamura K, Takashima S, Hamasaki H, Kawaguchi S, Miyamoto Y, Tanoue A (2010) The mood stabilizer valproic acid improves defective neurite formation caused by Charcot-Marie-Tooth disease-associated mutant Rab7 through the JNK signaling pathway. J Neurosci Res 88:3189–3197
Hirose M, Ishizaki T, Watanabe N, Uehata M, Kranenburg O, Moolenaar WH, Matsumura F, Maekawa M, Bito H, Narumiya S (1998) Molecular dissection of the Rho-associated protein kinase (p160ROCK)-regulated neurite remodeling in neuroblastoma N1E-115 cells. J Cell Biol 141:1625–1636
Mateus D, Marini ES, Progida C, Bakke O (2018) Rab7a modulates ER stress and ER morphology. Biochim Biophys Acta Mol Cell Res 1865:781–793
Loi M, Raimondi A, Morone D, Molinari M (2019) ESCRT-III-driven piecemeal micro-ER-phagy remodels the ER during recovery from ER stress. Nat Commun 10:5058

Table 1 is available in the Supplementary Files section.

No competing interests reported.

Download PDF

Version 1

posted

You are reading this latest preprint version

Knockdown of Rab7B, but not of Rab7A, which antagonistically regulates oligodendroglial cell morphological differentiation, recovers tunicamycin-induced defective differentiation in FBD-102b cells

Status:

Version 1

Abstract

Figures

1. Introduction

2. Materials And Methods

2.1. Antibodies and chemicals

2.2. siRNA and primer nucleotide sequences and PCR techniques

2.3. Cell culture, differentiation, and transfection

2.4. Cell lysis and immunoblotting

2.5. Statistical analyses

2. 6. Ethics Statements

3. Results

3.1. Rab7A positively affects morphological differentiation

3.1. Rab7B negatively affects morphological differentiation

3.3. Knockdown of Rab7B recovers tunicamycin-induced defective morphological differentiation

3.4. Knockdown of Rab7B recovers tunicamycin-induced ER stress signaling

4. Discussion

Declarations

References

Tables

Additional Declarations

Supplementary Files

Status:

Version 1